Raymund Razonable to Treatment Outcome
This is a "connection" page, showing publications Raymund Razonable has written about Treatment Outcome.
Connection Strength
0.114
-
Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019. J Infect Dis. 2021 10 28; 224(8):1278-1286.
Score: 0.035
-
Cytomegaloviraemia clearance with foscarnet during renal replacement therapy. J Antimicrob Chemother. 2018 02 01; 73(2):548-549.
Score: 0.027
-
Epidemiology, risk factors, and outcomes of infections in patients undergoing liver transplantation for hilar cholangiocarcinoma. Clin Transplant. 2017 08; 31(8).
Score: 0.026
-
GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia: A Case-Cohort Study. Mayo Clin Proc. 2020 11; 95(11):2382-2394.
Score: 0.008
-
Traveler's Diarrhea Recommendations for Solid Organ Transplant Recipients and Donors. Transplantation. 2018 02; 102(2S Suppl 2):S35-S41.
Score: 0.007
-
HHV-6 in liver transplantation: A literature review. Liver Int. 2018 02; 38(2):210-223.
Score: 0.007
-
A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients. Transpl Infect Dis. 2013 Oct; 15(5):487-92.
Score: 0.005